Pon Ayyappan S is an experienced professional in the pharmaceutical and engineering sectors, currently serving as Senior Manager at Maiva Pharma Private Limited since December 2020, focusing on FDA-approved sterile injectables. Prior roles include Junior Manager at Syngene International Limited and Officer II at Apotex Research Private Limited, where responsibilities encompassed GMP documentation, validations, and quality management systems. Pon's career also includes positions at Kemwell Pvt. Ltd. and Biocon, concentrating on engineering and maintenance operations. Pon's educational background includes a diploma in Electrical and Electronics Engineering from Tamilnadu Polytechnic College, Madurai, and an SSLC from Thigarajar Mills Hr Sec School, Kappalur, Madurai.
This person is not in any teams
Maiva Pharma Private Limited (FDA Approved Sterile Injectables)
Maiva Pharma Private Limited, formerly known as Global Pharmatech, started operations in 1996, as a manufacturer of high quality liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles. With a strong commitment to Quality and Compliance, Maiva has built a reputation in the industry for quality and reliability. The facility is capable of manufacturing both aseptically filled and terminally sterilized products. Maiva has USFDA EU-GMP, Health Canada, PIC/S, With two decades of experience in Sterile Manufacturing, Maiva have capabilities to perform end to end integrated pharmaceutical development and manufacturing ranging from literature search, formulation development, analytical methods development and validation, stability studies, global regulatory management, cGMP manufacturing till supply of commercial sterile injectables products. Maiva's facility spreads across a 5-acre plot, in Hosur, Tamil Nadu (outskirts of Bangalore). The manufacturing unit consists of an integrated ampoule line and an integrated glass vial line. In the last few years, Maiva has emerged as a prominent injectables manufacturer by leveraging India cost advantage and scientific talents and by following stringent quality systems. Offers:Injectables